Patent ID: 7192606

Claim:
N,N 1 -Bis(tricyclo[3.3.1.1 3,7 ]dec-1-yl)imidodisulfamide, a compound having a formula [R-(CR 2 R 3 ) n NHSO 2 ] 2 NR 1 (I) or pharmaceutically acceptable salts, solvates or isomers of said compound or salts or solvates of said isomers, wherein: n is a number from 0 to 6: R is a carbocyclic radical selected from the group consisting of adamantly, norbornyl, cyclooctyl, and cyclododecyl; R 1 is selected from the group consisting of hydrogen, alkali metal, ammonium cation, and monophosphate moiety; and R 2 and R 3 can be the same or different and are independently selected from a group consisting of H and lower alkyl; and further wherein said carbocyclic radical can be optionally substituted with one or more substituents selected from the group consisting of lower alkyl, F, Cl, Br, NO 2 and CF 3 , and encapsulated in a liposome formulation.